• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Teal Health Raises $10M, Launches the First At-Home Cervical Cancer Screening

by Jasmine Pennic 01/16/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Teal Health Raises $10M, Launches the First At-Home Cervical Cancer Screening

What You Should Know: 

– Teal Health, a women’s health company dedicated to eliminating cervical cancer, announced today it has raised an additional $10M in seed funding led by Emerson Collective and Forerunner, with continued support from existing investors like Serena Ventures and Metrodora, and a new partnership with Labcorp. 

– This latest investment brings the company’s total funding to $23M and will support the upcoming launch of the Teal Wand™, a groundbreaking at-home cervical cancer screening device currently under FDA review.

– This investment comes on the heels of significant milestones for Teal Health, including a $1.68 million Small Business Innovation Research (SBIR) grant from the National Cancer Institute and FDA Breakthrough Device Designation for the Teal Wand.

Addressing a Critical Need

Cervical cancer is a preventable disease, yet millions of women in the US are not getting screened regularly. Teal Health aims to change that. A recent nationwide clinical study conducted by Teal Health found that 94% of women preferred at-home screening with the Teal Wand over traditional in-clinic methods. This highlights the strong demand for a more user-friendly and convenient option.

How the Teal Wand Works

The Teal Wand is a self-collection device that allows women to collect a sample for human papillomavirus (HPV) testing, the primary screening method for cervical cancer. The sample is then mailed to a lab for analysis, and results are delivered securely through Teal Health’s telehealth platform. The Teal Wand is on track to become the first FDA-approved self-collect cervical cancer screening device in the US market. This innovative technology allows women to take control of their health and screen for cervical cancer in the comfort and privacy of their own homes.

This approach aligns with the latest guidelines from the United States Preventive Services Task Force (USPSTF), which recognizes the accuracy and effectiveness of self-collected HPV samples, particularly in reaching underscreened populations.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Femtech

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

HLTH 2025 Coverage

HLTH 2025 Day 1 Summary & Insights: AMA Launches AI Governance Center, Google Cloud, Microsoft, ChatGPT for Medicine

Featured Interview

ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing

Most-Read

Cleveland Clinic and Khosla Ventures Form Strategic Alliance to Accelerate Healthcare Innovation

Cleveland Clinic and Khosla Ventures Form Strategic Alliance to Accelerate Healthcare Innovation

Northwell Health Selects to Deploy Abridge’s Ambient AI Across 28 Hospitals

Northwell Health to Deploy Abridge’s Ambient AI Across 28 Hospitals

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Launches AI-Powered Meal Map to Transform Nutrition for Cardiometabolic Patients

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |